42 results
8-K
EX-99.1
ANNX
Annexon Inc
4 Mar 24
Regulation FD Disclosure
5:25pm
drug candidates that are under clinical investigation, and which have not yet been approved for marketing by the U.S. Food and Drug Administration (FDA
8-K
EX-4.1
t8b4iprjmbahzi8uh7a1
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
8-K
EX-1.1
5tnf4vo
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
8-K
EX-4.2
lgkp 3xo8uyupza
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.2
d0yl6t2umneusn 3xxx
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-10.1
2cl42k2k38vfch78
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-4.1
hcni5
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
o6jfhyx xz
10 Jan 22
Regulation FD Disclosure
6:40am